Bio-Techne slides after fiscal Q3 results show revenue decline and a miss versus consensus estimates

Bio-Techne Corporation (TECH) is down 12.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to Bio-Techne’s fiscal third-quarter 2026 earnings release, where reported results showed a year-over-year revenue decline and fell short of consensus expectations. Even with improved GAAP profitability, investors seemed to focus on the top-line softness and the company’s explanation that shipment timing and prior-year comparisons pressured growth.

Details:

Bio-Techne reported fiscal Q3 2026 revenue of $311.4 million, down 2% year over year (reported and organic).

The company cited prior-year GMP fast-track orders and the timing of large Commercial Supply shipments as notable headwinds to quarterly revenue.

Adjusted EPS was $0.53 for the quarter, down from $0.56 in the prior-year quarter.

GAAP EPS was $0.32, up from $0.14 a year earlier, helped by items that improved GAAP operating results versus the prior-year period.

Sources:

Bio-Techne Investor Relations, SEC, Zacks Investment Research

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$TECH Insider Trading Activity

$TECH insiders have traded $TECH stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $TECH stock by insiders over the last 6 months:

AMY E. HERR sold 1,976 shares for an estimated $116,791

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$TECH Hedge Fund Activity

We have seen 257 institutional investors add shares of $TECH stock to their portfolio, and 304 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 2,495,328 shares (+164.4%) to their portfolio in Q4 2025, for an estimated $146,750,239
MACQUARIE GROUP LTD removed 1,824,428 shares (-99.6%) from their portfolio in Q4 2025, for an estimated $107,294,610
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,801,049 shares (-81.0%) from their portfolio in Q4 2025, for an estimated $105,919,691
ALLIANCEBERNSTEIN L.P. added 1,447,516 shares (+157.8%) to their portfolio in Q4 2025, for an estimated $85,128,415
BAMCO INC /NY/ removed 1,288,824 shares (-51.6%) from their portfolio in Q4 2025, for an estimated $75,795,739
SG CAPITAL MANAGEMENT LLC added 1,149,129 shares (+inf%) to their portfolio in Q4 2025, for an estimated $67,580,276
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,138,721 shares (-97.2%) from their portfolio in Q4 2025, for an estimated $66,968,182

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$TECH Congressional Stock Trading

Members of Congress have traded $TECH stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $TECH stock by members of Congress over the last 6 months:

REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 5 times. They made 2 purchases worth up to $30,000 on 12/05, 12/02 and 3 sales worth up to $45,000 on 03/26, 02/24, 01/28.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

$TECH Analyst Ratings

Wall Street analysts have issued reports on $TECH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Argus Research issued a "Buy" rating on 11/20/2025

To track analyst ratings and price targets for $TECH, check out Quiver Quantitative's $TECH forecast page.

$TECH Price Targets

Multiple analysts have issued price targets for $TECH recently. We have seen 7 analysts offer price targets for $TECH in the last 6 months, with a median target of $76.0.

Here are some recent targets:

Daniel Markowitz from Evercore ISI Group set a target price of $54.0 on 04/06/2026
Brandon Couillard from Wells Fargo set a target price of $76.0 on 02/06/2026
Kyle Boucher from TD Cowen set a target price of $80.0 on 02/05/2026
Dan Leonard from UBS set a target price of $79.0 on 02/05/2026
Daniel Arias from Stifel set a target price of $65.0 on 02/05/2026
Patrick Donnelly from Citigroup set a target price of $80.0 on 02/05/2026
David Toung from Argus Research set a target price of $68.0 on 11/20/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.